Christopher S. Manganaris, MD
Pulmonary Disease Physician · Guntersville, AL
Christopher S. Manganaris, MD is a pulmonary disease physician with a practice address in Guntersville, Alabama, and NPI 1447394648, issued on Feb 19, 2007. Check the license (Alabama 30912, as entered in NPPES) on the Alabama Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Christopher S. Manganaris
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 30912 AL
Self-reported in NPPES; status is on the state search - Practice location
- 55 Rowe Drive, Guntersville, AL 35976
- Phone
- (256) 753-8810
- Enumerated
- Feb 19, 2007
- Record last updated
- Aug 28, 2012 (not updated in 14 years: call before relying on the address or phone)
- Fax
- (256) 753-8880
- Medicaid ID
- 134280 AL
- Medicare enrollment
- Enrolled (PECOS I20120410000069); may accept Medicare assignment
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 219 in Alabama → Look up another NPI →
Verify Christopher S. Manganaris in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersAlabama Board of Medical Examiners
Search for license 30912Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
54% more Medicare Part D claims than the average pulmonary disease physician in 2024
2,195 Medicare Part D claims for 318 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 63% of claims.
Most prescribed
- Albuterol Sulfate Hfa426 claims
- Trelegy Ellipta402 claims
- Breo Ellipta172 claims
- Prednisone119 claims
- Breztri Aerosphere92 claims
- Spiriva Respimat90 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,546.75
70 payments; by number, the most common kind was food and beverage; the largest payer was GlaxoSmithKline, LLC. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Marshall Medical Center South Manganaris PulmonologyGuntersville, AL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Christopher S. Manganaris among 219 pulmonary disease physician records in Alabama
Christopher S. Manganaris, MD is one of 219 pulmonary disease physician records with a practice address in Alabama. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 52% of them.
- NPI issued2007 · 52% of these records are older, 42% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated2004 · median 2003 among the 176 with a school on file
- Record last updated2012 · 44% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Alabama practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Alabama
There are 219 pulmonary disease physician records in Alabama.
All 219 in Alabama → Every provider in Guntersville → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Jenna Carpenter, D.O.Boaz, AL 359571144427006
- William Kuczerpa, MDBoaz, AL 359571730170978
- Ali Al-Tarbsheh, MDGadsden, AL 359031659932341
- Mazen Hakim, M.D.Gadsden, AL 359031114016920
- Muhammad Kaleem, MDGadsden, AL 359031285697078
- Kumudchandra Shah, MDGadsden, AL 359031922173277
- Sikander Zulqarnain, MDGadsden, AL 359011366751257
- Akshay Kumar Bajaj, M.D.Montgomery, AL 361061285607887
Common questions
What is Christopher S. Manganaris, MD's NPI number?
Christopher S. Manganaris, MD's National Provider Identifier (NPI) is 1447394648, issued on Feb 19, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Christopher S. Manganaris, MD located?
The NPPES record lists a practice address at 55 Rowe Drive, Guntersville, AL, 35976. Phone: (256) 753-8810. Providers update this record themselves, so call before visiting.
How can I verify Christopher S. Manganaris, MD's license?
NPPES lists Alabama license number 30912, as entered by the provider. Search the Alabama Board of Medical Examiners at https://www.albme.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Christopher S. Manganaris, MD prescribe under Medicare Part D?
In 2024, Christopher S. Manganaris, MD had 2,195 Medicare Part D claims for 318 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.